89 related articles for article (PubMed ID: 28385536)
1. Mining the topography and dynamics of the 4D Nucleome to identify novel CNS drug pathways.
Higgins GA; Allyn-Feuer A; Georgoff P; Nikolian V; Alam HB; Athey BD
Methods; 2017 Jul; 123():102-118. PubMed ID: 28385536
[TBL] [Abstract][Full Text] [Related]
2. The epigenome, 4D nucleome and next-generation neuropsychiatric pharmacogenomics.
Higgins GA; Allyn-Feuer A; Handelman S; Sadee W; Athey BD
Pharmacogenomics; 2015; 16(14):1649-69. PubMed ID: 26338265
[TBL] [Abstract][Full Text] [Related]
3. Network Reconstruction Reveals that Valproic Acid Activates Neurogenic Transcriptional Programs in Adult Brain Following Traumatic Injury.
Higgins GA; Georgoff P; Nikolian V; Allyn-Feuer A; Pauls B; Higgins R; Athey BD; Alam HE
Pharm Res; 2017 Aug; 34(8):1658-1672. PubMed ID: 28271248
[TBL] [Abstract][Full Text] [Related]
4. A glutamatergic network mediates lithium response in bipolar disorder as defined by epigenome pathway analysis.
Higgins GA; Allyn-Feuer A; Barbour E; Athey BD
Pharmacogenomics; 2015; 16(14):1547-63. PubMed ID: 26343379
[TBL] [Abstract][Full Text] [Related]
5. Failed drug discovery in psychiatry: time for human genome-guided solutions.
Papassotiropoulos A; de Quervain DJ
Trends Cogn Sci; 2015 Apr; 19(4):183-7. PubMed ID: 25727774
[TBL] [Abstract][Full Text] [Related]
6. Functional organization of the human 4D Nucleome.
Chen H; Chen J; Muir LA; Ronquist S; Meixner W; Ljungman M; Ried T; Smale S; Rajapakse I
Proc Natl Acad Sci U S A; 2015 Jun; 112(26):8002-7. PubMed ID: 26080430
[TBL] [Abstract][Full Text] [Related]
7. Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach.
Ogden CA; Rich ME; Schork NJ; Paulus MP; Geyer MA; Lohr JB; Kuczenski R; Niculescu AB
Mol Psychiatry; 2004 Nov; 9(11):1007-29. PubMed ID: 15314610
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional oscillation of canonical clock genes in mouse peripheral tissues.
Yamamoto T; Nakahata Y; Soma H; Akashi M; Mamine T; Takumi T
BMC Mol Biol; 2004 Oct; 5():18. PubMed ID: 15473909
[TBL] [Abstract][Full Text] [Related]
9. In vitro characteristics of valproic acid and all-trans-retinoic acid and their combined use in promoting neuronal differentiation while suppressing astrocytic differentiation in neural stem cells.
Chu T; Zhou H; Wang T; Lu L; Li F; Liu B; Kong X; Feng S
Brain Res; 2015 Jan; 1596():31-47. PubMed ID: 25463022
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics and therapeutic strategies for dementia.
Cacabelos R
Expert Rev Mol Diagn; 2009 Sep; 9(6):567-611. PubMed ID: 19732004
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of psychotropic drug response.
Malhotra AK; Murphy GM; Kennedy JL
Am J Psychiatry; 2004 May; 161(5):780-96. PubMed ID: 15121641
[TBL] [Abstract][Full Text] [Related]
12. Valproic acid regulates catecholaminergic pathways by concentration-dependent threshold effects on TH mRNA synthesis and degradation.
D'Souza A; Onem E; Patel P; La Gamma EF; Nankova BB
Brain Res; 2009 Jan; 1247():1-10. PubMed ID: 18976638
[TBL] [Abstract][Full Text] [Related]
13. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
[TBL] [Abstract][Full Text] [Related]
14. Mood stabilizing drugs regulate transcription of immune, neuronal and metabolic pathway genes in Drosophila.
Herteleer L; Zwarts L; Hens K; Forero D; Del-Favero J; Callaerts P
Psychopharmacology (Berl); 2016 May; 233(9):1751-62. PubMed ID: 26852229
[TBL] [Abstract][Full Text] [Related]
15. The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders.
Gray NA; Zhou R; Du J; Moore GJ; Manji HK
J Clin Psychiatry; 2003; 64 Suppl 5():3-17. PubMed ID: 12720479
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid phase shifts the rhythmic expression of Period2::Luciferase.
Johansson AS; Brask J; Owe-Larsson B; Hetta J; Lundkvist GB
J Biol Rhythms; 2011 Dec; 26(6):541-51. PubMed ID: 22215612
[TBL] [Abstract][Full Text] [Related]
17. SCAN: a systems biology approach to pharmacogenomic discovery.
Gamazon ER; Huang RS; Cox NJ
Methods Mol Biol; 2013; 1015():213-24. PubMed ID: 23824859
[TBL] [Abstract][Full Text] [Related]
18. Search for common targets of lithium and valproic acid identifies novel epigenetic effects of lithium on the rat leptin receptor gene.
Lee RS; Pirooznia M; Guintivano J; Ly M; Ewald ER; Tamashiro KL; Gould TD; Moran TH; Potash JB
Transl Psychiatry; 2015 Jul; 5(7):e600. PubMed ID: 26171981
[TBL] [Abstract][Full Text] [Related]
19. Novel drug-regulated transcriptional networks in brain reveal pharmacological properties of psychotropic drugs.
Korostynski M; Piechota M; Dzbek J; Mlynarski W; Szklarczyk K; Ziolkowska B; Przewlocki R
BMC Genomics; 2013 Sep; 14():606. PubMed ID: 24010892
[TBL] [Abstract][Full Text] [Related]
20. Initiation and adaptation: a paradigm for understanding psychotropic drug action.
Hyman SE; Nestler EJ
Am J Psychiatry; 1996 Feb; 153(2):151-62. PubMed ID: 8561194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
